Invited Speakers: Graham Allway------------- MBI Manchester
Rob Arnold------------------ Coopers & Lybrand
Stefan Bassarab----------- Boeringer Ingelheim
Mike Beatrice--------------- Quintiles
John Bremner-------------- Scottish Enterprise
Steven Burke--------------- North Carolina Biotech
Peter Calcotti--------------- Immunex
J.F. Carmier---------------- Transgene
Mike Carroll----------------- British Biotech
Sue Charles---------------- DeFacto
James Christie------------- Centocor
Mike Davies---------------- Lonza
Wayne Davies------------- Neuropa
Professor Horst Domdey BioMag Munich
Ross Durland-------------- GeneMedicine
Chris Evans---------------- Merlin Sciences Services Ltd
Edgar Fritschi-------------- BioGen Tec
Nigel Gaymond------------ Mass Biotech
Scott Greer----------------- Abgenix
Dr. Grunwald--------------- Forschungsgemeinschaft
Bill Hamilton---------------- Axis Genetics
Steve Hammond---------- Scottish Biomed Foundation
Juliann Hanak------------- Cobra
Paul Haycock-------------- Apax
Nick Heightman----------- Vanguard Medica
Nick Henry----------------- Fresenius
Chris Hill-------------------- Lonza
Mandy Hussey------------ Pharmaceutical Proteins
Markuu Jalkanen--------- Biotie
Ron James----------------- Pharmaceutical Proteins, Ltd
Kathy Lambert------------- Cantab Pharmaceuticals
Vicki Latter------------------ CP Pharmaceutical
Brian Lawliss--------------- Covance
Ms. Sam Madden--------- TAE Associates
Robert Mansfield----------- Vanguard Medica
Christie Mitchell------------ Quadrant
Inge Mollerup--------------- Novo Nordisk
Luis Nisbet------------------ Xenova
Frank Roberts------------- Bioprocessing
Spiro Rombotis------------ Cyclacel
Helmut Shuster----------- TVM Techno Venture
Leo Snel--------------------- Novo Nordisk
Alexander W Stasse--------------Rhein Biotech
Robert van Reis---------- Genentech
Friederich von Bohlen---- Lion Bioscience
Brian White----------------- Nat West
Ian Wilmut------------------ Roslin Institute
Program:
· The European Biotechnology Landscape in 2008
What will be the Prospects for Funding M & A Deals?
What will be the New Technologies ?
What impact will the Global Village have?
· Developments in Manufacturing - Getting Started
· Speeding up From Discovery to a Product
· Separation and Downsteam Processing
· The Current Start-up Environment in Europe
· How Effective Have Governments Been in Helping Start-ups?
· What are the Best Government Incentives to Encourage Start-ups?
· Discussion Forums on Government Initiatives, Bio-Incubators and
Mentoring followed by reports from each group.
· Developments in Analysis, Formulation and Stability Testing
· Growing Your Business/Valuation
· Packaging and Distributing Product to the Patient
· New and Imaginative Deal Structures
· Manufacturing New Chemical Entities - The Hurdles for Start-ups
· Manufacturing for Gene Therapy - the Hurdles for Start-ups
· Getting Products Made - The Bottlenecks in Manufacturing
· Dolly, One Year On
Registration :
USA - 914-834-3100, 914-834-3689
E-Mail hmatysko@liebertpub.com
EUROPE - +44 141 553 1930, +44 141 552 0511
E-Mail ebs@meetingmakers.co.uk
Deadline for Abstracts: Call or send E-mail
Email for Requests and Registration: hmatysko@liebertpub.com or ebs@meetingmakers.co.uk